Observe Medical ASA (DE:OM5A) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Observe Medical has secured its first order for the UnoMeter Safeti Plus in Thailand, a significant step in expanding its market presence. This follows successful sales of another product, UnoMeter 500, earlier in 2024, and contributes to the company’s strategy of reclaiming its 2021 sales levels. With orders now from 15 countries, Observe Medical is well-positioned for growth in the medtech sector.
For further insights into DE:OM5A stock, check out TipRanks’ Stock Analysis page.